<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02573792</url>
  </required_header>
  <id_info>
    <org_study_id>RDS_2015_21</org_study_id>
    <nct_id>NCT02573792</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography and Optic Neuritis (OCTON)</brief_title>
  <acronym>OCTON</acronym>
  <official_title>Optical Coherence Tomography for the Etiological Diagnosis of Inflammatory Optic Neuritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optic neuritis (ON) can remain isolated or reveal a widespread and chronic disease of the
      central nervous system (CNS), a multiple sclerosis (MS) or, more rarely, a Devic's
      neuromyelitis optica (NMO) or a systemic disease.

      The optical coherence tomography (OCT) is a retinal imaging technique to measure the
      thickness of the retina and its different layers with an accuracy of 4-6 µM.

      Costello et al have shown that approximately 75% of 54 MS patients have developed within 3 to
      6 months after a ON a loss of 10 to 40 µM in the thickness of the peripapillary retinal nerve
      fiber layer (RNFL).

      The etiologic diagnosis of ON has been transformed in recent years. MS can now be diagnosed
      by McDonald's MRI criteria and NMO by the AQP4 antibodies (anti-aquaporin- 4) antibodies and
      the anti-MOG (myelin-oligodendrocyte glycoprotein) antibodies.

      The diagnosis and prognosis value of the OCT in patients with ON is not well known
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 5, 2015</start_date>
  <completion_date type="Actual">July 2019</completion_date>
  <primary_completion_date type="Actual">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of the OCT, expressed as a percentage, for the etiological diagnosis of optical neuritis</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <enrollment type="Actual">120</enrollment>
  <condition>Optical Neuritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen at the Adolphe de Rothschild ophthalmological foundation for the first onset
        of an optical neuritis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first onset of an optical neuritis lasting for less than 3 months

        Exclusion Criteria:

          -  Contra-indication to MRI

          -  Patient opposed to participation in the study

          -  Pregnant or lactating woman

          -  Patient under a measure of legal protection

          -  Absence of affiliation to social security or universal health coverage (CMU)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>October 9, 2015</study_first_submitted>
  <study_first_submitted_qc>October 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2015</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>First onset of optical neuritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Optic Neuritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

